Company · CIK 0001919246 · SIC 2836 — Biological Products, (No Diagnostic Substances) · NYSE
Pelthos Therapeutics Inc. · PTHS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 SForm 4 → | Jul 7, 5:03 pm EDT | Ezra M FriedbergDirector | 558 | $26.09 | $14,556 | 81,042 | −0.68% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 7, 5:03 pm EDT | Matthew PaulsDirector | 786 | $26.16 | $20,561 | 14,364 | −5.19% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 7, 5:03 pm EDT | Peter GreenleafDirector | 797 | $26.13 | $20,827 | 23,884 | −3.23% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 5:25 pm EDT | Ezra M FriedbergDirector | 283 | $27.29 | $7,724 | 81,600 | −0.35% | 10b5-1 |
| Jun 11, 2026 PForm 4 → | Jun 15, 5:25 pm EDT | Todd C DavisDirector | 35,948 | $27.82 | $999,983 | 75,834 | +90.1% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.